Fundraising FoxNeraCare
Munich, DE · 2 known investors
Find your way into NeraCare
Sign up to see every warm intro you have to NeraCare
- Paths you didn't know you had: your email and LinkedIn already hold routes to the NeraCare team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
NeraCare develops clinically validated prognostic tests that personalize survival prediction and risk stratification for patients with early-stage melanoma, guiding adjuvant therapy decisions. The company operates as a partnership-driven diagnostics firm supporting clinical studies and collaborations across Europe and the U.S.
Founders & leadership
Investors · 2
In the news
Frequently asked questions
- What does NeraCare do?
- NeraCare develops clinically validated prognostic tests that personalize survival prediction and risk stratification for patients with early-stage melanoma, guiding adjuvant therapy decisions. The company operates as a partnership-driven diagnostics firm supporting clinical studies and collaborations across Europe and the U.S.
- Who founded NeraCare?
- NeraCare was founded by Friedrich Ackermann, Daniel von Janowski.
- Who are NeraCare's investors?
- NeraCare's investors include MIG Capital AG, BayBG Venture Capital.
- Where is NeraCare headquartered?
- NeraCare is headquartered in Munich, DE.